Investigators visit Mass. firm in meningitis case

October 17, 2012

(AP)—Criminal investigators from the Food and Drug Administration have visited a Massachusetts company whose steroid medication has been linked to a deadly meningitis outbreak.

FDA spokesman Steven Immergut said Tuesday the agents' work at the New England Compounding Center is part of the investigation into the outbreak, which has killed at least 15 people and sickened more than 200 others in 15 states. Nearly all the victims had received for back pain.

Company attorney Paul Cirel says it's "difficult to understand the purpose" of the FDA search. He says the company has been clear it would voluntarily provide anything investigators requested. He says the company will continue to cooperate.

Federal and state investigators say they've found in more than 50 vials from the company but haven't said whether they've pinpointed the contamination source.

Explore further: US: Avoid drugs from company tied to meningitis (Update)

shares

Related Stories

US clinics rush to warn of tainted steroid; 5 dead

October 5, 2012

(AP)—Health providers scrambled to notify patients in nearly two dozen U.S. states that the steroid injections they received for back pain may have been contaminated with a deadly fungal meningitis. Five people have died.

US pharmacy linked to outbreak issues wide recall

October 7, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

Mass. gov: Drug firm may have misled regulators

October 10, 2012

(AP)—Massachusetts Gov. Deval Patrick says the specialty pharmacy linked to a deadly meningitis outbreak may have misled regulators and done work beyond the scope of its state license.

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.